Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A randomized, double-blind, multicenter, placebo-controlled trial Academic Article uri icon

Overview

MeSH Major

  • Carbolines
  • Lower Urinary Tract Symptoms
  • Phosphodiesterase 5 Inhibitors
  • Prostate
  • Regional Blood Flow

abstract

  • Tadalafil for 8¬†weeks in men with BPH-LUTS did not result in detectable decreases in arterial RI or increases in CPI or CPD in the prostate or bladder neck. Detection of changes may not be possible because of already low baseline RI, insufficient sensitivity of techniques used, or may have been confounded by methodologic variability across sites. Alternatively, other possible mechanisms not assessed in this study may be more prominently involved.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.urology.2014.02.063

PubMed ID

  • 24938580

Additional Document Info

start page

  • 412

end page

  • 9

volume

  • 84

number

  • 2